ApoE isoforms can be considered either protective (ApoE2) or a major risk for AD development (ApoE4), and, interestingly, ApoE4 homozygotes display, during asymptomatic stages even decades before the AD onset, a similar regional hypometabolism compared to AD patients, as observed with glucose tracers [46]. This evidence concerns the gene APOE and Alzheimer disease.